Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

NCT07636200 is registered in ClinicalTrials.gov with University of Colorado, Boulder as lead sponsor.

NCT NCT07636200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07636200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
Lead sponsor
University of Colorado, Boulder
Phase
Not applicable
Overall status
Recruiting
Start date
May 4, 2026
Completion date
May 31, 2030
Enrollment
250 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor cancer, glioblastoma, small cell lung cancer extensive stage, stage iii ovarian cancer, stage iv cancer (solid tumors only)